PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Bohnacker, S. ; Henkel, F. ; Hartung, F. ; Geerlof, A. ; Riemer, S. ; Prodjinotho, U.F.* ; Salah, E.B.* ; Mourao, A. ; Bohn, S. ; Teder, T.* ; Thomas, D.* ; Gurke, R.* ; Böckel, C. ; Ud-Dean, M. ; König, A.-C. ; Quaranta, A.* ; Alessandrini, F. ; Lechner, A. ; Spitzlberger, B. ; Kabat, A.M.* ; Pearce, E.J.* ; Haeggström, J.Z.* ; Hauck, S.M. ; Wheelock, C.E.* ; Jakobsson, P.J.* ; Sattler, M. ; Voehringer, D.* ; Feige, M.J.* ; da Costa, C.P.* ; Esser-von Bieren, J.

A helminth enzyme subverts macrophage-mediated immunity by epigenetic targeting of prostaglandin synthesis.

Sci. Immunol. 9:eadl1467 (2024)
Verlagsversion DOI PMC
Free by Publisher
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
The molecular mechanisms by which worm parasites evade host immunity are incompletely understood. In a mouse model of intestinal helminth infection using Heligmosomoides polygyrus bakeri (Hpb), we show that helminthic glutamate dehydrogenase (heGDH) drives parasite chronicity by suppressing macrophage-mediated host defense. Combining RNA-seq, ChIP-seq, and targeted lipidomics, we identify prostaglandin E2 (PGE2) as a major immune regulatory mechanism of heGDH. The induction of PGE2 and other immunoregulatory factors, including IL-12 family cytokines and indoleamine 2,3-dioxygenase 1, by heGDH required p300-mediated histone acetylation, whereas the enzyme's catalytic activity suppressed the synthesis of type 2-promoting leukotrienes by macrophages via 2-hydroxyglutarate. By contrast, the induction of immunoregulatory factors involved the heGDH N terminus by potentially mediating interactions with cellular targets (CD64 and GPNMB) identified by proteomics. Type 2 cytokines counteracted suppressive effects of heGDH on host defense, indicating that type 2 immunity can limit helminth-driven immune evasion. Thus, helminths harness a ubiquitous metabolic enzyme to epigenetically target type 2 macrophage activation and establish chronicity.
Impact Factor
Scopus SNIP
Altmetric
17.800
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Ccp4 Suite; Cells; Inflammation; Polarization; Activation; Expression; Phenotype; Proteome; Type-1; Focus
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 2470-9468
e-ISSN 2470-9468
Zeitschrift Science immunology
Quellenangaben Band: 9, Heft: 102, Seiten: , Artikelnummer: eadl1467 Supplement: ,
Verlag American Association for the Advancement of Science (AAAS)
Verlagsort Washington, DC
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
Institute of Structural Biology (STB)
Institute of Computational Biology (ICB)
CF Metabolomics & Proteomics (CF-MPC)
POF Topic(s) 30202 - Environmental Health
30203 - Molecular Targets and Therapies
30205 - Bioengineering and Digital Health
Forschungsfeld(er) Allergy
Enabling and Novel Technologies
PSP-Element(e) G-554600-001
G-505400-001
G-503000-001
G-503800-001
G-505700-001
A-630700-001
Förderungen Swedish Research Council
Swiss National Science Foundation
Helmholtz Young Investigator grant by the Helmholtz Initiative and Networking Fund
German Federal Ministry of Education and Research (BMBF)
German Research Foundation
DOI 10.1126/sciimmunol.adl1467
WOS ID 001372628200002
Scopus ID 85211750904
PubMed ID 39642243
Erfassungsdatum 2024-12-10
[➜Korrektur melden]